NCT06326697View on ClinicalTrials.gov

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

August 17, 2025

Study Completion Date

August 28, 2025

Conditions
Acute Myeloid Leukaemia
Interventions
DRUG

Azacitidine

Azacitidine 300 mg Film coated tablets

DRUG

Onureg

Azacitidine 300 mg Film coated tablets

Trial Locations (1)

Unknown

King Faisal Specialist Hospital and Research Centre, Riyadh

Sponsors
All Listed Sponsors
lead

Hikma Pharmaceuticals LLC

INDUSTRY

NCT06326697 - Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML) | Biotech Hunter | Biotech Hunter